45 results
Page 2 of 3
8-K/A
EX-99.3
kmz1mmzm9onuffao21a
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
8-K/A
EX-99.1
rqbraermn qnyklh
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
8-K/A
EX-99.2
50qvhmtyd
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
8-K
EX-99.3
5ufbp flp4160z
9 Mar 21
ImmunityBio and NantKwest Complete Merger
9:58pm
DEFM14A
s33eqvfvetv jssyf
2 Feb 21
Proxy related to merger
6:10am
424B3
dp8mg
2 Feb 21
Prospectus supplement
6:05am
S-4/A
kwd6zeshi003b6pxw
29 Jan 21
Registration of securities issued in business combination transactions (amended)
5:01pm
S-4/A
EX-99.1
yrhu70nm8lj1myrmd
29 Jan 21
Registration of securities issued in business combination transactions (amended)
5:01pm
S-4
bmwsla8
19 Jan 21
Registration of securities issued in business combination transactions
5:20pm
8-K
EX-99.1
o0sc2fj301jo h8u
26 Oct 20
NantKwest Names Richard Adcock Chief Executive Officer
5:05pm